Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is AT&T Stock a Buy Now?


AT (NYSE: T) posted its second-quarter report on July 26. Its revenue rose 1% year over year to $29.9 billion, which missed analysts' estimates by $30 million. Its adjusted earnings per share (EPS) fell 3% to $0.63 but beat the consensus forecast by three cents.

AT's stock barely budged after that mixed report, and it remains down nearly 20% this year. It certainly looks cheap AT six times forward earnings and pays a hefty forward dividend yield of 7.5% -- but is it a worthwhile long-term investment?

Image source: AT

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,051 €
3,06 %
Die Allergy Therapeutics PLC Aktie erlebt heute einen großen Anstieg von 3,06 %.

Like: 0
T
Teilen

Kommentare